NTRK1 and diabetic macular edema: After VEGF-R2 is activated, the processes of tyrosine kinase receptor increases, leading to the activation of a variety of downstream signaling pathways and damage to the internal and external retinal barriers, important pathological mechanisms in the pathogenesis of diabetic macular edema (DME) [63].